Prot# INCB 08721-204: DECLARE 1 (DExelvucitabine Compared to Lamivudine in Anti-Retroviral Experienced Subjects-1)A Rndmzd, Dbl-Blnd, Phs II Study Comparing the Anti-Retroviral Safety & Efficacy of Dexelvucitabine(DFC)200mg 1x Daily to
- Sutton, Sarah H (PD/PI)
Project: Research project